News
State registration for the medicinal product Gidazepam VIC has been finished
17 AprilVIVA Pharm informs you about the receipt of marketing authorizations for the medicinal product Gidazepam VIC in the following dosage forms: tablets 20 mg (RK-MP-5 №022914) and 50 mg (RK-MP-5 №022915), sublingual tablets 20 mg (RK-MP-5 №022916) and 50 mg (RK-MP-5N022917). The medicinal product refers to the pharmacotherapeutic group of psychotropic agents (anxiolytics, benzodiazepine derivatives).
